Omics! Omics!

At the beginning of the weekend I received a real shock: one of the other father's in TNG's Cub Scout Pack had died of sepsis after ...

I have an invited piece on the various sequencing instruments over at MolBio Research Highlights . The fact that much of it is an extended...

Okay, a little bragging: I biked into to work last week for Bike to Work week. I actually bike the last leg of my commute a lot of days now ...

A consistently reappearing thread in any bioinformatics discussion space is "What programming language should I learn/teach?". As...

The world is abuzz with the announcement by Craig Venter and colleagues that they have successfully booted up a synthetic bacterial genome. ...

I've only seen it a few times, but the sight of the iconic cavernous building always makes my heart race. But this time even more so, a...

Two weeks ago I participated in a roundtable sponsored by the Massachusetts Technology Leadership Council (MassTLC) titled "R&D IT ...

When learning a new language, it is tempting to fall back on the patterns of a previous language. This isn't always a bad thing but is ...

A review by me titled " Application of Second Generation Sequencing to Cancer Genomics " is now available on the Advance Access se...

I recently got around to reading the "Human Genome at 10" issue of Nature. One feature, on facing pages, are opinion pieces by Ro...

Well, it was inevitable. A huge (and expensive) case of confused human genome versions. While the human genome is 10 years old, that was ha...

An item last week in GenomeWeb covered a new analysis by Robin Cook-Deegan and colleagues of the Myriad BRCA patents. One bit in particula...

I've spent some time the last few weeks trying to remember what I learned in freshman biology. Partly this has been triggered by planni...

A characteristic of each of the existing second generation sequencing instruments is that each manufacturer provides its own collection of s...

Last weekend was the Academy Award presentations. Fittingly, just before I had my first theatrical success -- with Actors. Actors are a Sca...

If you watch this space by RSS, make sure you catch the additions and corrections by BioIT World's Kevin Davies and my fellow Codon Devi...

Today was the last day of the Marco Island conference, so I won't be hammering Twitter again for quite a while. The afternoon session f...

Last night I finally got my paws on a paper which started out on a frustrating tack. Last week, a flurry of news items heralded a new appro...

The Marco Island Advances in Genome Biology and Technology , or AGBT (or just Marco Island) conference started up today. Whatever weather t...

The Scientist has a profile of Aaron Ciechanover , who shared the Nobel Prize for work on the proteasome. His Nobel-cited work began in his...